Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.075 USD | +5.67% | +4.07% | +10.83% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.83% | 104M | |
+43.18% | 750B | |
+34.11% | 606B | |
-6.70% | 356B | |
+18.96% | 326B | |
+6.94% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.03% | 167B |
- Stock Market
- Equities
- CLRB Stock
- News Cellectar Biosciences, Inc.
- Oppenheimer Adjusts Cellectar Biosciences Price Target to $12 From $47, Maintains Outperform Rating